Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.
about
Combination HIV prevention: significance, challenges, and opportunitiesInterventions to modify sexual risk behaviours for preventing HIV in homeless youth.Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug usersPreconception care: delivery strategies and packages for carePreconception care: preventing and treating infectionsMen in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial.The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African AmericansThe past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal studyBrief and intensive behavioral interventions to promote sexual risk reduction among STD clinic patients: results from a randomized controlled trial.HIV/AIDS and drug use in China--interactions, impacts, and issues.Update on the Epidemiology and Prevention of HIV/AIDS in the United States.Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for female military personnel.Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users.Cognitive behavioral theories used to explain injection risk behavior among injection drug users: a review and suggestions for the integration of cognitive and environmental models.Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.A systematic review of reviews of behavioral interventions to promote condom use.Prevention of HIV infection among injection drug users in resource-limited settings.The Global HIV Archive: Facilitating the Transition from Science to Practice of Efficacious HIV Prevention Interventions.HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: a structural equation modeling approach.Meta-analyses of seven of the National Institute on Drug Abuse's principles of drug addiction treatment.Progress in HIV reduction and prevention among injection and noninjection drug users.Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trialNIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.Psychosocial and behavioral correlates of anxiety symptoms in a sample of HIV-positive, methamphetamine-using men who have sex with men.Evaluation of WaySafe: A Disease-Risk Reduction Curriculum for Substance-Abusing OffendersCommunity Providers' Impression of HIV Prevention Intervention Research in NIDA's Clinical Trials NetworkBehavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.Even if you build it, we may not come: correlates of non-attendance at a sexual risk reduction workshop for STD clinic patients.Understanding sexual abstinence in urban adolescent girls.Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations.Qualitative analysis of cocaine and heroin users' main partner sex-risk behavior: is safety in love safety in health?Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells.Barriers to practicing risk reduction strategies among people who inject drugs.Effects of behavioral intervention on substance use among people living with HIV: the Healthy Living Project randomized controlled study
P2860
Q22252603-91C4103E-8A09-4609-A927-16F9604A7B41Q24234944-E744F91E-9019-41B9-9AC5-BD1BF36DB8A0Q24240762-B2BE144A-000D-415C-8FE1-A23836CEBC4CQ26828937-1617A1FB-DE7B-4943-B62F-1A0887090883Q26996391-D3D4558E-2BC6-4C13-82AB-A1E45710FF20Q30495573-D21C3FC4-07B9-4016-9217-972C72223F79Q30543309-6A3B73B5-F7F4-4130-B614-7FD6EF18A67EQ33828458-2A6F3D81-ABD4-4385-8A75-39E841AF00A2Q33833339-5E5E1731-F596-43AC-A30D-723BBDE292B9Q34076064-932DB9AD-193E-42FF-BA61-5133F05568D8Q34119447-43773984-A916-4CEC-9D42-2EFFD1AABB55Q34669756-E2BC9340-7156-4C1F-86FB-6F61B62A0A3BQ34690277-F570E765-9B3D-4CD8-BCCA-1583DE704544Q34766519-8A1566CF-7079-4EE8-BDE2-D01296F1E28EQ34881643-B62BA051-8699-42EF-8459-396F8A77B1A0Q34890135-20EAD837-69DE-418B-BCEC-5521087CD014Q35015974-CD2F0CE3-4BAA-4AFD-867D-2E96C859E2D4Q35043964-3D87E195-A9C8-4699-976B-8F5D80DEA9A8Q35101096-56DEC57D-31C1-4C80-87EA-4DCB91BC5913Q35143605-B1D70E99-EC0F-43A4-A374-86E39CF4DBAEQ35203629-95D7F9B1-2037-4D22-AE6E-482D77A179FDQ35680763-3F01CC33-E3EF-4397-856D-1010C7AD2982Q35791179-DF0C5CCD-38FE-48D7-B7FB-7DCD0E895463Q35816921-641AA6FA-BFDC-45F9-957B-5112A9DB3207Q35981551-B26D6EC8-A5B8-425C-A84D-40A7EAD8DD03Q35990579-C3DF3432-8080-44A2-9269-F61C0CE7E4FDQ36073797-F88377E5-420A-4563-8F14-7F138AFAAF14Q36090200-589E53E9-B65F-4560-B9B1-213DA86284A5Q36507265-7640A0E0-54D5-4DA5-BA86-5D0FC6819DF4Q36508384-1B4EBB30-85DB-479A-903A-D11817429DCAQ36552540-E5C83D51-AD41-44E3-B3F2-E69A228210EBQ36622863-65C85F15-7765-4242-ACFD-C2D5BC2F9227Q36703513-29FB2642-F39F-457F-A6E6-9E70A39A33D9Q36767274-C338950F-A7A9-4F61-B50B-28DCBEBBD3A5Q36905229-333F6705-38AF-4740-BCF4-7B69F106CDA2Q36960952-0700B6EB-CB56-468F-9262-F531FCB1D303Q36972758-1671F176-28FB-40EE-B09C-B12123C4AEE7Q37007347-83A0FC7A-4250-4176-A393-3754B062C20FQ37149214-BB0E9522-71A7-4060-A284-D3DC124A14B6Q37151415-FF904412-A9B0-4F0B-97F0-6C837D835EAF
P2860
Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@ast
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@en
type
label
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@ast
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@en
prefLabel
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@ast
Behavioral HIV risk reduction ...... analytic evidence of efficacy.
@en
P2093
P2860
P1476
Behavioral HIV risk reduction ...... -analytic evidence of efficacy
@en
P2093
Blair T Johnson
Jennifer J Harman
Michael M Copenhaver
Michael P Carey
SHARP Research Team
P2860
P304
P356
10.1016/J.JSAT.2006.04.002
P50
P577
2006-07-13T00:00:00Z